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Abstract
Chemokines control cell migration in many contexts including development, homeostasis, immune surveillance and
inflammation. They are also involved in a wide range of pathological conditions ranging from inflammatory diseases and
cancer, to HIV. Chemokines function by interacting with two types of receptors: G protein-coupled receptors on the
responding cells, which transduce signaling pathways associated with cell migration and activation, and glycosaminogly-
cans on cell surfaces and the extracellular matrix which organize and present some chemokines on immobilized surface
gradients. To probe these interactions, imaging methods and fluorescence-based assays are becoming increasingly desired.
Herein, a method for site-specific fluorescence labeling of recombinant chemokines is described. It capitalizes on previously
reported 11–12 amino acid tags and phosphopantetheinyl transferase enzymes to install a fluorophore of choice onto a
specific serine within the tag through a coenzyme A-fluorophore conjugate. The generality of the method is suggested by
our success in labeling several chemokines (CXCL12, CCL2, CCL21 and mutants thereof) and visualizing them bound to
chemokine receptors and glycosaminoglycans. CXCL12 and CCL2 showed the expected co-localization on the surface of
cells with their respective receptors CXCR4 and CCR2 at 4uC, and co-internalization with their receptors at 37uC. By contrast,
CCL21 showed the presence of large discrete puncta that were dependent on the presence of both CCR7 and
glycosaminoglycans as co-receptors. These data demonstrate the utility of this labeling approach for the detection of
chemokine interactions with GAGs and receptors, which can vary in a chemokine-specific manner as shown here. For some
applications, the small size of the fluorescent adduct may prove advantageous compared to other methods (e.g. antibody
labeling, GFP fusion) by minimally perturbing native interactions. Other advantages of the method are the ease of bacterial
expression, the versatility of labeling with any maleimide-fluorophore conjugate of interest, and the covalent nature of the
fluorescent adduct.
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Introduction
Chemokine-mediated cell migration is a complex process
involving many dynamic steps including transport of chemokines
across cells, presentation of chemokines on cell surface glycosami-
noglycans (GAGs) and extracellular matrix components, binding
of chemokines to their G protein-coupled receptors (GPCRs), and
scavenging and transport of chemokines by atypical chemokine
receptors [1–4]. Binding to receptors typically involves monomeric
forms of chemokines. However homo- and hetero- oligomerization
has also been shown to play important roles in the overall
regulation and function of the chemokine system [5–9]. In order to
understand the complex interactions and dynamic mechanisms
involved in chemokine biology and to track their spatial and
temporal dependence, fluorescence and bioluminescent imaging
methods have become important tools. In this study we focused on
the development and application of exogenously added fluorescent
chemokines, and to this end a number of studies have been
previously reported: the fluorescent protein eGFP, the biolumi-
nescent protein luciferase, and streptavidin coated fluorescent
quantum dots have been fused or conjugated to the C-terminus of
CXCL12 in investigations of the scavenging function of the
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chemokine receptor CXCR7 [10–12]. Similarly, CCL2-mCherry
has been used to monitor the scavenging function of CCR2 during
the migration of monocytes [13]. Fluorescent chemokines have
also been used to detect binding interactions with receptors [14].
While these and other reports establish the utility of using
fluorescent chemokines to study receptor interactions, many of the
above examples involve fusions with large fluorescent/biolumi-
nescent proteins that can interfere with interactions, and often
require expression in eukaryotic cells which is time-consuming
compared to bacterial expression systems. Additionally, some
genetically encoded GFP-like fusions tend to oligomerize, which
may be undesirable [15]. Detection with fluorescent anti-
chemokine antibodies, while a method of choice for detecting
endogenous chemokine, can be suboptimal if the antibody blocks
interactions with other chemokines, GAGs or receptors, or does
not recognize chemokines when they are complexed to other
macromolecules.
To solve some of these problems, covalent labeling of
chemokines with small organic dyes has been pursued [14].
Non-specific covalent labeling of chemokines through amine-
coupling chemistry is the simplest method and is commonly used
for antibodies and many other proteins. However, given that the
N-termini of chemokines are critical for signaling [16] and that
lysine residues are frequently involved in chemokine interactions
with GAGs and chemokine receptors [17], labeling in this manner
is likely to alter the function of the ligand. Accordingly, site-specific
labeling methods are preferred. Along these lines, we recently
introduced a non-native cysteine residue at the C-termini of
chemokines CCL14/HCC-1(amino acids 9-74) and CCL7/MCP-
3, and labeled them with maleimide conjugated fluorophores
which are widely available with a broad array of emission
wavelengths [18]. As expected, this strategy resulted in the
production of fluorescent chemokines that were fully functional
because modification of the C-termini, including attachment of
fusion proteins, generally has little effect on receptor interactions.
The disadvantage of this approach is that one must ensure that the
extra cysteine does not interfere with correct folding and disulfide
bond formation of the other native cysteine residues (all
chemokines contain one-three disulfides, the majority have two).
The method worked well for CCL7 and CCL14 because these
chemokines are expressed in soluble form with no need for
refolding to promote formation of the two structural disulfides, and
they are well behaved in solution with little tendency to
oligomerize. However, when applied to other chemokines, we
encountered difficulties with aggregation and low yield due to the
formation of disulfide-linked dimers or scrambled disulfides.
Synthetic approaches for making site specifically labeled chemo-
kines have been described and can limit inappropriate disulfide
formation by the use of different protecting groups on the native
and non-native cysteines [14]. While such chemokines are
available commercially, they are quite expensive.
As an alternative approach we investigated the use of recently
described genetically encoded peptide tags that can be labeled with
phosphopantetheinyl transferase enzymes (PPTases) [19,20]. The
initial 11 amino acid tag was derived from B. subtillis and then
subject to phage display to identify modified sequences that can be
orthogonally labeled based on differential specificities of B. subtillis
Sfp and E. coli AcpS PPTases. We focused primarily on the S6 tag,
which is a good substrate for Sfp. In this report we describe the
preparation of chemokine-fluorescent conjugates, demonstrate
that they are functional, and illustrate their use in microscopy
and flow cytometry-based approaches for interrogating interac-
tions with receptors and GAGs.
Materials and Methods
Materials
All chemicals were purchased from Sigma-Aldrich, unless
otherwise specified.
Protein expression, purification and fluorescent labeling
For all chemokines used in this study, the DNA sequence coding
for the S6 tag, GGCGATAGCCTGAGCTGGCTGCTG-
CGCCTGCTGAACTAA, (translation: GDSLSWLLRLLN-stop)
was inserted immediately after the codon for the C-terminal
residue. Chemokines were expressed and purified as described
previously [18,21]. The Sfp enzyme was a gift from Professor Jun
Yin (University of Chicago) and was expressed and purified as
described previously [22]. All fluorescent probes used in this study
(Table 1) were purchased from Invitrogen, with the exception of
Cy3B (GE Healthcare) and NPM (Sigma). The coenzyme A
(CoA)-fluorophore conjugates were prepared as described previ-
ously [22], and lyophilized following purification by C18 reversed-
phase HPLC. Prior to the labeling reaction, the stock concentra-
tion of the dye conjugate was determined by the maximum UV/
VIS absorbance, using the extinction coefficients published by the
dye manufacturers. Protein concentration was determined by the
absorbance at 280 nm. The labeling reaction was initiated by
mixing the S6-tagged chemokine, the CoA-fluorophore conjugate,
and the Sfp enzyme at a final concentration of 10 mM, 10 mM,
and 2 mM, respectively, in 50 mM HEPES, 10 mM MgCl2,
pH 7.2. The reaction was incubated at room temperature in the
dark for 30 min, and the labeled protein was lyophilized following
purification by C18 reversed-phase HPLC. The molecular weights
of the labeled products were validated by ESI mass spectrometry.
Mammalian cell culture and transfection
Jurkat cells (ATCC) and U937 cells (gift of Jeffrey D. Esko, UC
San Diego) were maintained in RPMI 1640 media (Invitrogen)
supplemented with 10% fetal bovine serum (FBS). HEK293t cells
were obtained from ATCC and maintained in Dulbecco’s
modified Eagle medium (DMEM) with Glutamax (Invitrogen)
supplemented with 10% FBS. Transient transfections of these cells
with pcDNA3.1-S6-CCR7 and pcDNA3.1-CCR2-YFP were
carried out using TransIT-LT1 reagent (Mirus Bio). HEK293s
cells used for the scintillation proximity assay were stably
transfected with an inducible pACMV-tetO-flag-CXCR4 plasmid
and pcDNA6/TR (Invitrogen) according to the manufacturer’s
protocol and maintained in DMEM/10% FBS with blasticidin
and G418. The Chinese hamster ovary cells (CHO-K1) and
PGS745 cells (gift of Jeffrey D. Esko, UC San Diego) [23] were
maintained in DMEM/F12 nutrient mixture (Gibco) supplement-
ed with 10% FBS. Transient transfections of CHO-K1 cells with
pcDNA3.1-Flag-CXCR4, pcDNA3.1-CXCR4-GFP (gift of
Adriano Marchese, Loyola University), pmEos2-CCR7 (with
CCR7 placed C-terminally to mEos2), and CCR5-mCherry were
carried out using the TransIT CHO transfection kit (Mirus Bio).
Scintillation proximity assay (SPA)
HEK293s cells stably transfected with pACMV-tetO-flag-
CXCR4 were treated with doxycycline (2 mg/ml) and sodium
butyrate (5 mM) for 24 h to induce CXCR4 expression. The cells
were added to a Corning NBS 96-well plate at 50,000 cells per
well, along with 0.4 mg of wheat germ agglutinin (WGA) beads
(Perkin Elmer), 0.5 mCi 125I-CXCL12 (0.2 nM final concentra-
tion, Perkin Elmer), and the appropriate amount of unlabeled
competitor ligand (WT CXCL12, a P2G-CXCL12 antagonist
mutant, or S6-tagged CXCL12) in 20 mM HEPES pH 7.2
Site Specific Fluorescent Labeling of Chemokines
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containing Hank’s Balanced Salt Solution (Gibco) and 0.1% BSA.
The cells were incubated at room temperature for 1 h with
shaking, and the resulting scintillation was recorded on a
MicroBeta TriLux 1450 Scintillation and Luminescence Counter
(Perkin Elmer). Triplicate measurements were made for each
concentration point, and their average and the SEM (standard
error of the mean) were reported in CPM. IC50 values were
estimated by fitting the data to the one-site model equation:
CPM~CPMminz
CPMmax{CPMmin
1z10(x{log IC50)
where x is the log of ligand concentration. GraphPad Prism
version 5 (GraphPad Software) was used to perform the fit as well
as the fits to the calcium mobilization assay described below.
Calcium mobilization assay
The FLIPR Calcium 4 Assay Kit (Molecular Devices) was used
for the calcium mobilization assays. Jurkat cells or U937 cells were
centrifuged in a poly-D-lysine-coated 96-well black/clear bottom
plate (Becton Dickinson Labware) at 160,000 cells per well and
incubated in 200 ml 50 mM HEPES pH 7.4 containing Hank’s
Balanced Salt Solution (HBBS, Gibco) with the Calcium indicator
at 37uC for 90 min as per manufacturer’s instructions. Cells were
stimulated by the addition of 50 ml HEPES/HBBS containing the
appropriate ligand, and their response was recorded for 150 s
using a Flex Station 3 plate reader (Molecular Devices). Triplicate
measurements were made for each concentration point, and the
average of the maximum signal intensity at each concentration
and the SEM were reported in Relative Fluorescence Units. EC50
values were estimated by fitting the data into the one-site model
equation:
RFU~RFUminz
RFUmax{RFUmin
1z10(x{logEC50)
where x is the log of ligand concentration.
Migration assay
Corning 6.5 mm Transwell plates (24 wells) with 5.0 mm
polycarbonate permeable membrane inserts were used for the
migration assays. Jurkat cells or U937 cells were resuspended at
2.56106 cells/ml with RPMI/10% FBS then 100 ml of suspension
were added to the inserts and placed over the lower chamber
containing 600 ml of the same medium with the appropriate
amount of ligand. The number of cells that migrated to the lower
chamber after 2 h of incubation at 37uC was recorded by Guava
EasyCyte 8HT flow cytometer (EMD Millipore). Triplicate
measurements were made for each concentration point, and their
average and SEM are reported as the % of the total input.
Flow cytometry
Surface expression of Flag-CXCR4 in CHO-K1 cells was
detected using PE-conjugated rat anti-human CD184 (CXCR4)
and the PE-conjugated rat IgG2a k monoclonal isotype control
antibodies (BD Biosciences). Cells were lifted from tissue culture
dishes using Cellstripper cell dissociation solution (Cellgro),
washed with ice cold PBS+0.1% BSA (FACS buffer), and stained
in FACS buffer supplemented with 4 mg/mL of either anti-human
CD184 or isotype control for 45 min in the dark on ice. In the case
of cell staining with fluorescent CXCL12 derivatives, the same
procedure was used, except that the staining FACS buffer was
supplemented with 100 nM of an antagonist variant of CXCL12-
Alexa647 (LGG-CXCL12, manuscript in preparation); the antag-
onist was used to ensure that the chemokine treatment would not
cause receptor internalization. For both antibody and CXCL12-
Alexa647 staining, the cells were washed three times with FACS
buffer and fixed with 0.8% paraformaldehyde (PFA) before flow
cytometric analysis. For AMD3100 treatment, the FACS buffer
was supplemented with 1 mM AMD3100. For heparinase treat-
ment, cells were incubated with 1 mg/ml heparin lyase I, II, and
III (Sigma-Aldrich) for 4 h at 37uC and washed with FACS buffer
immediately prior to staining with LGG-CXCL12-Alexa647. For
heparin washed cells, 100 mg/ml heparin was added to the FACS
buffer for the three final washes. The flow cytometry was carried
out using a Guava EasyCyte 8HT flow cytometer (EMD
Millipore), and the data was analyzed using FlowJo version 7.5.5
(Tree Star, Inc.) and GraphPad Prism version 5 (GraphPad
Software). Results were analyzed for significant differences using
two-tailed t-tests. The resultant P-values are indicated in the figure
legend as follows: n.s., P.0.05; *, P,0.05; **, P,0.01; ***,
P,0.005.
Fluorescence Microscopy
For detection of CXCR4:CXCL12 localization, 100,000 CHO-
K1 cells were seeded overnight onto a 18 mm microscope cover
glass pre-coated with human plasma fibronectin (Millipore) in 1 ml
Table 1. Mass spectrometry validation of fluorescently
labeled chemokines.
Fluorophore Chemokine
DMW
observeda
DMW
expectedb
Alexa Fluor 647 CXCL12 1323 NA
LGG-CXCL12c 1324 NA
CXCL12 K24S/H25S/K27S 1323 NA
CCL2 1323 NA
CCL7 1324 NA
CCL21 1324 NA
vMIP-II 1324 NA
Alexa Fluor 488 CXCL12 1040 1038
CXCL12 K24S/H25S/K27S 1041 1038
CXCL12 H25R 1040 1038
CXCL12 P2G 1040 1038
Cy3B CXCL12 1024 NA
LGG-CXCL12c 1024 NA
NPM CXCL12 639 638
CCL2 640 638
CPM CXCL12 ND ND
aMolecular weight of the adduct (dye and the phosphopantetheinyl arm of
coenzyme A) in Daltons as determined by mass spectrometry following the
PPTase reaction, assuming the formation of the appropriate number of disulfide
bonds for the given chemokine.
bTheoretical molecular weight of the adduct based on the published structure
of the dye.
cCXCL12 mutant with CXCR4 antagonist properties developed in our laboratory
(manuscript in preparation).
Abbreviations: PPTase, phosphopantetheinyl transferase. NA, not available. ND,
not determined. CPM, 7-diethylamino-3-(49-maleimidylphenyl)-4-
methylcoumarin. NPM, N-(1-pyrenyl)maleimide. GAG, glycosaminoglycan. vMIP-
II, viral macrophage inflammatory protein-II.
doi:10.1371/journal.pone.0081454.t001
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1:1 DMEM/F12 nutrient mixture (Gibco) with 10% FBS on a 12
well culture plate (Corning) and transfected with pcDNA3.1-
CXCR4-GFP the following day. A day after the transfection, cells
were stained in 500 ml serum-free media supplemented with
100 nM CXCL12-CPM for 30 min on ice, washed with PBS/
0.5% BSA, and fixed with 4% PFA in PBS at room temperature.
Cells for the internalization assays were stained and washed as
above, incubated in 1 ml serum-free media at 37uC for 30 min,
washed with PBS/0.5% BSA and fixed with 4% PFA in PBS. The
cover glasses were mounted onto microscope slides with Fluor-
osave Reagent (Calbiochem).
For detection of CCL2:CCR2 localization, HEK293t cells were
transfected with pcDNA3.1-CCR2-YFP and stained as above,
using 100 nM CCL2-Alexa647, with the exception that DMEM
was used in the place of DMEM/F12.
For the direct detection of CCL21-Alexa647:CCR7/GAG
interaction, CHO-K1 and PGS745 cells were transiently trans-
fected with pcDNA3.1-CCR7-mEos2. Cells were lifted with
10 mM EDTA in PBS and stained in suspension for 30 min on
ice in PBS/0.5% BSA containing CCL21-Alexa647 at concen-
trations indicated in the main text and figure legends. Stained cells
were washed in PBS/0.5% BSA on ice and fixed in 4% PFA at
room temperature. Fixed cells were washed in water and
resuspended in 70% ethanol and air-dried on a glass cover slip
before being mounted onto a slide with Fluorosave Reagent. The
CHO-K1 and PGS745 cells expressing CXCR4-GFP were
stained with CXCL12-Alexa647 but otherwise treated as above.
These images were collected using an Olympus IX81 DSU
spinning disk confocal microscope configured with a PlanApo 606
oil objective and Hamamatsu ORCA-ER digital camera (Hama-
matsu, Hamamatsu, Japan). For adherent cell staining, fluorescent
images of XY-sections at 0.28 mm were collected sequentially
using SlideBook 4.2 software (Intelligent Imaging Innovations,
Denver, CO). XY-sections of 1.0 mm were collected for in-
suspension staining. The final composite images were created
using Photoshop CS4 and Illustrator CS4 (Adobe, San Jose, CA).
For immunofluorescence detection of CCL21, HEK293t cells
were transfected with CCR7, cultured, and a subset treated with
heparinase (2.5 mU/ml heparin lyases I, II, and III) for 30 min at
37uC. Cells were then harvested using 10 mM EDTA in PBS
followed by cytospin onto glass slides (16105 cells/spot). Samples
were then incubated with either 10 nM Alexa647-labeled or WT
recombinant human CCL21 (R&D), washed twice with cold PBS,
fixed in 4% PFA, blocked with PBS/1%BSA at room temperature
for 1 h, and stained with anti-CCL21 (R&D, 1:100) at 4uC
overnight. In some cases, cells were treated with a CCR7 blocking
antibody (R&D, 1:100) during the incubation with the respective
recombinant CCL21 species. After several PBS wash steps, the
cells were incubated with biotinylated secondary antibody (Vector
Labs, 1:500) at room temperature for 1 h followed by Cy3-
conjugated streptavidin (Jackson, 1:1000). To determine if
chemokine was membrane localized, cells were co-stained with
wheat germ agglutinin (WGA) conjugated to Alexa 488 (Invitro-
gen) following the manufacturer’s instructions. After washing, the
cells were mounted with VectaShield containing DAPI (Vector
Labs). Images were recorded with a Nikon Eclipse 80i fluorescence
microscope. To assess the extent of interaction, the areas occupied
by both CCL21 signal (Red) and DAPI (Blue) were quantified, and
the CCL21/DAPI ratio in the untreated sample was defined as 1,
and the relative binding in all other samples is expressed as its
fraction.
Results
Enzymatic Labeling of S6-tagged Chemokine
Previously, we described a method for fluorescent labeling of
chemokines by adding an extra cysteine to the C-terminus
followed by coupling to maleimide-conjugated fluorophores. The
main drawback of this method is low yield because the non-native
cysteine causes formation of inappropriate intra- and inter-
chemokine disulfides, especially with chemokines that require
refolding from inclusion bodies. The goal of this study was to
establish a relatively generic and cost-effective alternative method
that avoids the need for the introduction of non-native cysteine
residues. The site-specific protein-labeling method developed by
Yin and coworkers utilizes the phosphopantetheinyl transferase
(PPTase) reaction, in which a genetically encoded peptide tag is
modified with the phosphopantetheinyl (Ppant) arm of coenzyme
A, and, by extension, any molecule that can be coupled to the
sulfhydryl group of CoA [19,20]. The size of the adduct (a 12-
residue ‘‘S6 tag’’ and the Ppant arm of CoA) is small relative to
chemokines, and it does not rely on an unpaired cysteine. As it can
be installed at the C-termini of proteins, we reasoned that it could
be a general method for fluorescent labeling of all or most
chemokines without significantly affecting function.
To this end, we generated several expression constructs in which
the S6 tag was fused to the C-terminal residue of the chemokine
coding sequence (Table 1). All of these constructs were expressed
insolubly in E. coli, purified and labeled according to the scheme
shown in Figure 1a. The labeling was done according to the
published procedure [22], with the exception that the dye-CoA
conjugate was used in an equimolar ratio relative to chemokine, as
opposed to the 2:1 ratio specified in the original protocol, in order
to maximize the yield with respect to the dye. Figure 1b shows
the HPLC trace of a typical labeling reaction, in which S6-tagged
CXCL12 (CXCL12-S6) was labeled with the CoA-conjugate of
Alexa Fluor 488 yielding CXCL12-Alexa488. The trace indicates
that there is only a small amount of unlabeled chemokine
following the 30 min labeling reaction; thus the reaction can be
carried out at a stoichiometric dye-to-protein ratio without
sacrificing labeling efficiency. Mass spectrometry analysis of the
product showed a molecular weight of 10,367, which is within two
daltons of the expected molecular weight. Similar results were
obtained with several other chemokines and mutants (Table 1),
indicating that the PPTase method is highly efficient, specific and
that it is potentially applicable to many chemokines. The yield
with respect to the input chemokine is ,40–50%; most losses
occur during the labeling reaction where precipitation is often
observed, and during the lyophilization step due to sticking to the
container. It may be possible to minimize losses at the labeling
stage through the use of buffer additives, or alternate tags and
PPTase combinations, but we have not yet explored these
modifications. Nevertheless, the yield of desired product is quite
acceptable in comparison to the traditional cysteine-modification
approach.
CXCL12-S6 is functional
Having established that the PPTase scheme is an effective
alternative to other conventional methods of labeling chemokines
with organic fluorophores, we investigated the functionality of the
S6-tagged chemokines relative to their WT counterparts.
Figure 2a shows the result of a scintillation proximity assay
(SPA) for determining the binding affinity of WT CXCL12, a P2G
antagonist mutant of CXCL12 [24], and CXCL12-S6 for
CXCR4 expressed in HEK293 cells. IC50 values were 7.2 nM
for WT, 78 nM for P2G-CXCL12, and 33 nM for CXCL12-S6.
Site Specific Fluorescent Labeling of Chemokines
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The apparent affinity of WT CXCL12 for CXCR4 has been
reported to vary between 1 and 10 nM [25–27], and as 9 nM for
P2G-CXCL12 [24]. This suggests that the binding affinity
determined from our experiment was lower than the actual values
by up to ,9-fold for both WT CXCL12 and P2G-CXCL12.
Because CXCL12 requires G protein coupling for high affinity
binding [28], we speculate that the reason for the lower affinity
observed in this experiment (and related to the range of affinities
reported in the literature) is due to overexpression of CXCR4 from
the inducible promoter coupled with limiting amounts of
heterotrimeric G protein. Regardless of the actual numbers, our
results indicate that the affinity of CXCL12-S6 for CXCR4 is
lower than WT by ,5-fold and higher than the P2G-CXCL12
mutant by ,2-fold. Applying this correction to literature values,
we suggest that the affinity of interaction between CXCR4 and
CXCL12-S6 is in the 5–10 nanomolar range, which correlates
with the results of other functional assays discussed below.
The ability of CXCL12-S6 to activate receptor was then
evaluated in a calcium flux assay. In this experiment, Jurkat cells,
which express endogenous CXCR4, were stimulated with various
amounts of ligand, and the resulting calcium release signal was
recorded as a function of time (Figure 2b). Non-linear least
squares fitting of the dose response curve yielded EC50 values of
1.2 nM and 16 nM for the WT CXCL12 and CXCL12-S6,
respectively, in good agreement with the estimated binding affinity
discussed above (Figure 2c).
The ability of CXCL12-S6 to induce cell migration was also
examined. In this experiment, Jurkat cells were placed in the top
chamber of a bare filter transwell assay setup, and the number of
cells that migrated towards chemokine in the lower chamber after
2 h was determined by flow cytometry (Figure 2d). Consistent
with the binding and calcium flux data, the potency of the
CXCL12-S6 is reduced from that of the WT CXCL12 by ,13-
fold, with the maximum migration taking place at ,12 nM and
,0.9 nM, respectively. To ensure these observations were not cell-
line specific, the calcium flux assay and the migration assay were
repeated with U937 cells, which also express endogenous CXCR4,
and virtually identical results were obtained for both experiments
(Figure S1). These results suggest that CXCL12-S6 behaves
much like the WT protein, with only slightly reduced functionality
due to the reduced binding affinity. As described below, the
fluorescent-labeled chemokines are also able to effectively inter-
nalize receptor, another indicator of functionality.
Flow cytometry detection of chemokine interactions with
receptors and GAGs
In order to further establish CXCR4-specific surface binding by
the fluorophore-conjugated CXCL12, we stained CHO-K1 cells
with an Alexa-647 labeled antagonist variant of CXCL12 (LGG-
CXCL12-Alexa647) and performed flow cytometric analysis. We
first confirmed that CHO-K1 cells do not express endogenous
CXCR4, whereas CXCR4 was detected by rat anti-human
CD184 (CXCR4) (BD Biosciences) on the surface of cells
transiently transfected with Flag-CXCR4 (Figure S2). As
expected, surface staining with LGG-CXCL12-Alexa647 was
greatest for CXCR4-transfected cells (Figure 3). Addition of the
competitive small molecule CXCR4 antagonist AMD3100,
partially, but not completely, blocked CXCL12 binding. A
complete reduction was not expected since chemokines also bind
GAGs. Consistent with this, a further reduction in LGG-
CXCL12-Alexa647 surface staining of control pcDNA-transfected
cells was observed by either washing with heparin or treating with
heparinase I, II, and III. Thus both cell surface CXCR4 and
GAGs can be fluorescently labeled on live cells using the CXCL12
analogue.
Confocal microscopy imaging of chemokine:receptor
localization
In order to demonstrate the imaging potential of the fluores-
cently labeled CXCL12 derivatives, we transfected CHO-K1 cells
with CXCR4-GFP and stained them with CXCL12-CPM. We
note that much of the CXCR4-GFP was detected intracellularly as
observed by others for certain cell types [29,30]. However, a
previous study determined that the relative distribution was similar
Figure 1. Production of fluorescently labeled chemokines. (A)
Overview of the process for fluorescent labeling of chemokine. (B) HPLC
trace of CXCL12-Alexa488. (C) A schematic view of the CXCL12-S6
modified by the PPTase reaction in (B). Alexa Fluor488 C5 maleimide is
colored green. The moiety colored magenta is the phosphopantethei-
nyl arm of coenzyme A, whose b-phosphate had been attacked by the
deprotonated Ser 71 side chain in the S6 tag (sequence
GDSLSWLLRLLN; uncolored). The theoretical molecular weight of this
adduct is 1038 Da. The S6 tag is fused directly to the C-terminus of
CXCL12, comprising the total of 80 residues (9328 Da).
doi:10.1371/journal.pone.0081454.g001
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to that of CXCR4 that was not GFP-coupled [30]. As shown in
Figure 4a (see also Figure S3), surface labeling by CXCL12-
CPM localizes with CXCR4-GFP fluorescence at the cell surface
when the labeling is done at 4uC. Moreover, when the cells stained
with CXCL12-CPM were allowed to grow again at 37uC for
30 min, the CPM signal on the cell surface was lost and abundant
intracellular puncta appeared, many of which co-localized with the
CXCR4-GFP fluorescence, suggesting extensive internalization of
CXCL12 and CXCR4 had happened (Figure 4b). These data
indicate that (i) the fluorescent CXCL12 derivatives can be used to
image CXCR4 on cells via microscopy, (ii) that the fluorescent
CXCL12 derivatives are functional as they promote receptor
internalization, and (iii) that the fluorescent CXCL12 derivatives
can be followed through at least the initial endocytosis of the
CXCL12-bound receptors.
Essentially the same results were obtained when CCL2-
Alexa647 was used to stain HEK293t cells transfected with
CCR2-YFP. At 4uC, CCL2-Alexa647 was seen on the surface of
cells expressing CCR2 (Figure 4c), and virtually no staining was
detected on untransfected cells (not shown). After incubation at
37uC, abundant internal puncta were observed, revealing inter-
nalization of the labeled chemokine with receptor, and evidence of
the functionality of the ligand (Figure 4d).
CCL21 was also labeled with Alexa647 using the PPTase
strategy and used to detect CCR7 on the surface of CHO-K1 cells.
In our initial attempts, however, we encountered background
staining on the cover slip, on which the transfected cells had been
seeded, significantly higher than that observed with CXCL12 or
CCL2, and imaging in the adherent settings used in Figure 4 was
not suitable for this system. Cells in this experiment were harvested
first with EDTA/PBS and then either stained and fixed in
suspension before being mounted on the slides (for the direct
detection of CCL21-Alexa647) or deposited onto a slide by
cytospin prior to staining (for the immunofluorescence detection).
As shown in Figure 5, the staining of CHO-K1 cells expressing
CCR7-mEos2 by CCL21-Alexa647 resulted in an unusual pattern
of large puncta on the cell surface. Moreover, cells bearing these
large structures generally had only one or two of them. To make
sure the results were not an artifact of the CCL21-Alexa647, an
alternative secondary immunofluorescence approach was used to
visualize the CCL21 localization. In this case CCR7 transfected
HEK293t cells were incubated with either WT CCL21 or CCL21-
Alexa647 and subsequently treated with the immunofluorescence
reagents (see Materials and Methods), and in both cases, the large
puncta were again observed (Figure 6), indicating that both WT
CCL21 and the CCL21-Alexa647 form these structures and that
the localization pattern seen in Figure 5 is not unique to CCL21-
Alexa647. Binding sites were on the plasma membrane, as
evidenced by co-localization with the membrane marker wheat
germ agglutinin (WGA) lectin. Upon treatment with CCR7-
blocking antibody or heparinase, the binding of both labeled and
WT CCL21 was markedly reduced (Figure 6a and b), suggesting
that both GAG and CCR7 are required for the formation of these
unusual structures and that the fluorescent analogue also retained
this aspect.
To determine if these large CCL21 clusters are chemokine-
specific, CXCL12-Alexa647 and CCL21-Alexa647 bound to
CHO-K1 cells transfected with their respective receptors were
Figure 2. Functional assays of the S6-tagged CXCL12. (A) Scintillation proximity assay of the CXCR4:CXCL12-S6 interaction. HEK293s cells
expressing CXCR4 were incubated with 125I-labeled CXCL12, and the amount of cell-bound radioactivity was measured in the presence of WT CXCL12
(green), P2G-CXCL12 (blue) and CXCL12-S6 (red). The IC50 was estimated to be 7.2 nM for WT CXCL12, 78 nM for P2G-CXCL12, and 33 nM for CXCL12-
S6. (B) Calcium mobilization analysis of the signaling capability of CXCL12-S6. Jurkat cells were stimulated with CXCL12-S6 at the indicated
concentrations, and the cytoplasmic calcium release was recorded as a function of time. (C) Calcium mobilization dose-response curve for WT CXCL12
(green) and CXCL12-S6 (red). The maximum signal intensity shown in (B) was plotted as a function of the ligand concentration. The EC50 was
estimated to be 1.2 nM for WT CXCL12 and 16 nM for CXCL12- S6. . Results of the same experiment with U937 cells are shown in Figure S1a. (D)
Migration of Jurkat cells induced by WT CXCL12 (green) and CXCL12-S6 (red). Cells were stimulated with various concentrations of ligands, and the
results are expressed as the % of input cells that migrated to the lower chamber of the Transwell plate. Results of the same experiment with U937
cells are shown in Figure S1b.
doi:10.1371/journal.pone.0081454.g002
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compared using the in-suspension method of staining (Figure 7).
CXCL12-Alexa647 imaged on CHO-K1 cells transfected with
CXCR4-GFP showed a uniform staining of the cell surface,
peppered with occasional small puncta distributed across the cell
surface (Figure 7d, left panel). These small puncta seem to be
staining of GAGs, as they are also seen with the untransfected cells
(Figure 7d, right). Consistent with this notion, staining of
PGS745, mutant CHO cells defective in GAG synthesis initiation
[31], transfected with CXCR4 resulted in surface staining with a
smoother appearance, devoid of the small-puncta pattern
(Figure 7e, left), suggesting that the former is the component of
staining due to the receptor. CCL21-Alexa647 imaged on CHO-
K1 cells expressing CCR7, on the other hand, did not show a
similar continuous surface stain but rather the large, asymmetric
puncta, along with the small structures similar to those seen with
CXCL12-Alexa647 on the CHO-K1 cells (Figure 7a, left), while
the same experiment with the untransfected cells showed only the
latter component (Figure 7a, right). This indicates that the
formation of the large CCL21 cluster is contingent on the
expression of CCR7, even though its co-localization with the
receptor is not obvious in Figure 5 (i.e. it does not colocalize with
the highest density/brightest spots of CCR7). It also appears,
however, that the receptor alone does not support the growth of
the large CCL21 puncta, for staining of the PGS745 cells
transfected with CCR7 led to asymmetric puncta of reduced sizes
(Figure 7b, left), again suggesting the role of proteoglycans in
these unusual structures.
Discussion
The goal of this study was to establish a method for fluorescent
labeling of chemokines that is cost-effective and straightforward,
does not interfere with function, and is generally applicable to
many chemokines. The use of the PPTase reaction as a general
scheme for labeling of chemokines has several advantages relative
to other methods in that the ‘‘S6’’ tag is a small 12-residue tag, the
chemokine-S6 tagged constructs can be expressed in bacteria
rather than in more complicated eukaryotic systems, and they can
be produced as soluble proteins or as insoluble proteins followed
by refolding, both without the complications introduced by extra
Figure 3. Flow cytometry analysis of the binding of LGG-
CXCL12-Alexa647 to CXCR4 and GAGs on CHO-K1 cells. Shown
are MFI (median fluorescence intensity) values6 SEM percentage of the
maximum, after staining with LGG-CXCL12-Alexa647 in triplicate.
Shown from left to right are FLAG-CXCR4-transfected CHO-K1 cells,
FLAG-CXCR4-transfeceted CHO-K1 cells stained in the presence of 1 mM
AMD3100, pcDNA3.1-transfected CHO-K1 cells, heparinase treated
pcDNA3.1-transfected CHO-K1 cells, and pcDNA3.1-transfected CHO-
K1 cells washed with heparin after staining. Staining was performed in
triplicate and analyzed for significant differences by two-tailed t-tests.
The resultant P values are: CHO K1+CXCR4/none vs CHO K1+pcDNA/
none, 0.0071; CHO K1+CXCR4/none vs CHO K1+CXCR4/AMD3100,
0.0243; CHO K1+CXCR4/AMD3100 vs CHO K1+pcDNA/none, 0.3315;
CHO K1+pcDNA/none vs CHO K1+pcDNA/heparinase, 0.0001; CHO
K1+pcDNA/none vs CHO K1+pcDNA/heparin wash, 0.0001. The
resultant P-values are indicated within the figure as follows: n.s.,
P.0.05; *, P,0.05; **, P,0.01; ***, P,0.005.
doi:10.1371/journal.pone.0081454.g003
Figure 4. Microscopy imaging of chemokine-receptor interac-
tions and chemokine-mediated receptor internalization. (A)
CHO-K1 cells transiently transfected with CXCR4-GFP were stained with
100 nM CXCL12-CPM at 4uC. Left, CXCR4-GFP fluorescence. Middle,
CXCL12-CPM. Right, merged image. (B) CHO-K1 cells expressing CXCR4-
GFP were incubated at 37uC for 30 min following the surface staining at
4uC with CXCl12-CPM. Left, CXCR4-GFP. Middle, CXCL12-CPM. Right,
merged image. (C) Staining of HEK293t cells transiently expressing
CCR2-YFP by CCL2-Alexa647 at 4uC. Left, CCR2-YFP fluorescence.
Middle, CCL2-S6-Alexa647. Right, merged image. (D) HEK293t cells
expressing CCR2-YFP were incubated at 37uC for 30 min following the
surface-staining with CCL2-Alexa647 at 4uC. Left, CCR2-YFP. Middle,
CCL2-Alexa647. Right, merged image. (Scale bar: 10 mm).
doi:10.1371/journal.pone.0081454.g004
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unpaired cysteines. The method also allows one to choose from a
wide array of maleimide-conjugated fluorophores as well as other
maleimide chemical conjugates.
In this study, the S6-tag was fused to the C-termini of
chemokines so as not to disturb their N-termini, which are known
to be crucial for receptor activation. All S6 constructs studied here
expressed to a similar extent as the untagged constructs and
yielded 5–10 mg of purified material from 1 L LB cultures. Thus
we have no reason to think this will not be the case for other
chemokines, provided that reliable refolding conditions could be
worked out. The major source of product loss is during the PPTase
conjugation reaction and during the lyophilization step, and while
the yields are entirely acceptable from our perspective, there is
room for optimization to minimize losses by altering buffer
conditions and construct design. We have also observed the loss of
labeled products within 2–3 h when reconstituted in water, PBS,
or TBS at or below 1 mM. This problem can be alleviated by
reconstituting the labeled proteins at 5 mM or above. Other
additives such as DMSO, may also resolve this issue if lower stock
concentrations are desired.
The results of the functional studies indicate that the S6-tagged
CXCL12 retains the activity of the WT protein, albeit with a light
reduction in potency. Based on receptor binding competition
assays, we estimate the dissociation constant for the interaction
between CXCL12-S6 and CXCR4 to be within the 5–10 nM
range, which represents a 5–10-fold reduction in affinity. Results
of calcium mobilization and migration assays for CXCL12-S6 also
demonstrated a slight reduction in potency, which mirrors the
reduced affinity. Despite these minor perturbations to chemokine
activity, the results show that these labeled chemokines are useful
for probing their interactions with receptors and GAGs. We
observed that the surface staining of CHO-K1 cells by CXCL12-
Alexa647 was strongly dependent on the expression of CXCR4,
and the interaction was reduced in response to the treatment with
AMD3100, a small molecule inhibitor of CXCR4. Further
reduction in binding was observed when the cells were enzymat-
ically treated to digest the GAGs displayed on the cell surface or
when the staining was done in the presence of heparin as a
competitor. We also found that the receptor-specific binding of the
CXCL12-CPM could be visualized by microscopy and that the
co-localization of chemokine and receptor could be monitored
through the early stages of internalization. Identical results were
obtained when HEK293t cells expressing CCR2 were probed with
Figure 5. Microscopy imaging of CCL21 on CCR7 expressing
cells using CCL21-Alexa647. CHO-K1 cells expressing CCR7-mEos2
were stained in suspension for 30 min on ice with (A) 100 nM, (B)
50 nM, and (C) 25 nM CCL21-Alexa647. Left, CCR7-mEos2 fluorescence.
Middle, CCL21-Alexa647. Right, merged image. (A) and (C) show that
the puncta are clearly on the outside of the cell. (B) shows that
occasionally multiple puncta are observed. (Scale bar: 10 mm).
doi:10.1371/journal.pone.0081454.g005
Figure 6. Microscopy imaging of CCL21 on CCR7 expressing
cells by immunofluorescence. (A) Binding patterns for both 647-
labeled and unlabeled CCL21 (10 nM) show a punctate binding pattern
on the surface of HEK293t cells transfected with CCR7. Labeled or
unlabeled recombinant human CCL21 were incubated with HEK293t
cells, and binding was detected by immunofluorescence staining. Red
signal: CCL21; blue signal: DAPI nuclear stain; green signal: membrane
staining by wheat germ agglutinin (WGA) conjugated to Alexa-fluor
488(Scale bar: 50 mm). (B) To assess the extent of interaction, the areas
occupied by both CCL21 signal (Red) and DAPI (Blue) were quantified,
and the CCL21/DAPI ratio in the untreated sample was defined as 1, and
the relative binding in all other samples is expressed as its fraction.
doi:10.1371/journal.pone.0081454.g006
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fluorescently labeled CCL2. These findings demonstrate that it is
possible to use these reagents to monitor the interactions of
chemokines with both receptors and GAGs both in static and
dynamic processes such as internalization.
In the case of CCL21, we noticed the presence of unusually
large and discrete puncta of CCL21 on CCR7 expressing cells.
This cell-staining pattern was observed with direct detection of
CCL21-Alexa647 and with secondary-immunofluorescence stain-
ing methods applied to both WT CCL21 and CCL21-Alexa647,
implying that it is a consequence of CCL21 and not of the
fluorescent tag. Direct comparison of CXCL12-Alexa647 with
CCL21-Alexa647 also showed that the formation of puncta on
these cells is specific and unique to CCL21. Furthermore,
formation of the puncta was dependent on both CCR7 and
proteoglycan, as blocking with anti-CCR7 antibodies, treatment
with heparinase, or use of cells deficient in glycosaminoglycan
synthesis, all caused a significant reduction in the presence of these
structures. In this regard, it is noteworthy that prior studies
characterized CCR7 and heparan sulfate as co-receptors for
CCL21 accumulation on hLECs and important for recruitment of
CCR7-expressing tumor cells [32].
Interestingly, punctate or large depositions of CCL21 have been
noted in other studies aimed at examining the localization of
CCL21 in and around human lymphatic endothelial cells (hLECs).
Some studies have reported intracellular depots of CCL21 within
LECs from in vivo imaging of tissue explants of mouse ear sheets
and in cultured primary hLECs where it is secreted after TNFa-
stimulation [33]. Discrete puncta of CCL21 have been also
observed extracellular to initial lymphatic endothelial cells bound
to collagen-IV, where the localization was suggested to promote
the docking of dendritic cells to the LECs prior to transmigration
[34]. Our studies with HEK293 and CHO-K1 cells, and prior
studies with primary hLECs [32], suggest that CCR7 and
proteoglycans might also cluster CCL21 on cell surfaces, which
may contribute to formation of CCL21 gradients.
In summary, we report that the PPTase reaction can be
successfully applied to fluorescent labeling of chemokines. They
show use in fluorescence imaging by microscopy and flow
cytometry. Indeed, a recent study suggests that using fluorescent
chemokines may be preferred over fluorescent anti-chemokine
receptor antibodies [35]. Microscopy imaging of fluorescently
labeled CCL2 and CXCL12 showed the expected patterns of cell
surface labeling of receptor-transfected cells. However, CCL21
showed unusual but not unprecedented punctate structures. Thus
it seems that the PPTase method holds promise as a general
solution for generating fluorescent chemokines to gain information
regarding the spatial and temporal behavior of chemokines when
the use of exogenously added ligand is the method of choice.
Supporting Information
Figure S1 Functional assays of the S6-tagged CXCL12.
(A) Dose response curve of calcium mobilization assay on U937
cells for the WT CXCL12 (green) and CXCL12-S6 (red). (B)
Migration of U937 cells induced by the WT CXCL12 (green) and
CXCL12-S6 (red).
(TIF)
Figure S2 CXCR4 expression in CHO cells. CXCR4 is
expressed in CHO-K1 cells only after transfection. The CHO-K1
cells, which were transfected with either FLAG-CXCR4 or empty
pcDNA3.1 vector for the experiment shown in Figure 3, were
Figure 7. Comparison of CCL21-Alexa647 labeling of CCR7
transfected CHO cells to CXCL12-Alexa647 labeling of CXCR4
transfected CHO cells. (A) CHO K1 cells and (B) the GAG-deficient
mutant PGS745 cells were stained with 100 nM CCL21-Alexa647, with
(left panel) or without (right panel) the transfected CCR7-mEos2 (Scale
bar: 10 mm). Only the chemokine fluorescence is shown for clarity. (C) A
cartoon representation of the CCL21 staining patterns observed in (A)
and (B) is shown in blue color. Cells expressing CCR7-mEos2 are shown
in green. Untransfected cells are colored gray. (D) CHO K1 cells and (E)
PGS745 cells were stained with 100 nM CXCL12-Alexa647, with (left
panel) or without (right panel) the transfected CXCR4-GFP (Scale bar:
10 mm). Only the chemokine fluorescence is shown for clarity. (F) A
cartoon representation of the CXCL12 staining patterns observed in (D)
and (E) is shown in blue color. Cells expressing CXCR4-GFP are shown in
green. Untransfected cells are colored gray.
doi:10.1371/journal.pone.0081454.g007
Site Specific Fluorescent Labeling of Chemokines
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e81454
stained with PE-conjugated rat anti-human CD184 (CXCR4) and
the PE-conjugated rat IgG2a k monoclonal isotype control
antibodies (BD Biosciences). Shown in the figure are the resultant
histograms for isotype control (filled grey) staining, as well as for
pcDNA3.1 transfected (grey) and FLAG-CXCR4 transfected
(black) cells.
(TIF)
Figure S3 Microscopy imaging of chemokine-receptor
interactions and chemokine-mediated receptor inter-
nalization. Magnified views of the fields shown in Figure 4. (A)
CHO-K1 cells transiently transfected with CXCR4-GFP and
stained with 100 nM CXCL12-CPM at 4uC. (B) CHO-K1 cells
expressing CXCR4-GFP were incubated at 37uC for 30 min
following the surface-staining with CXCL12-CPM at 4uC. (C)
Staining of HEK293t cells transiently expressing CCR2-YFP by
CCL2-Alexa647 at 4uC. (D) HEK293t cells expressing CCR2-
YFP were incubated at 37uC for 30 min following the surface-
staining with CCL2-Alexa647 at 4uC. (Scale bar: 10 mm).
(TIF)
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